Gardasil vaccine (HPV) is divided into several groups: two-valent, four-valent, and nine-valent
All boys and girls aged 9 to 11 years are candidates for vaccination.
Any of the vaccines in whatever capacity is available. Between the ages of 11 and 9, only two doses are needed at an interval of 0 and 6 months. Age 15 to 21 years for boys and 15 to 26 years for girls need to receive three doses of the vaccine. All women in the age group of 17 to 45 years are candidates to receive are HPV vaccines.
The effectiveness of the vaccine after 45 years is insignificant. There is no need to receive a booster dose except when a person has received 2- or 4-valent vaccines, and now after a few years a 9-valent vaccine is available, otherwise there is no need to receive a booster dose.
Gardasil vaccine is one of the most important vaccines in the prevention of human papilloma virus (HPV), which can lead to the occurrence of various cancers, including cervical cancer, oral and pharyngeal cancer, and anal cancer. In recent years, many researches and advances have been made in the field of Gardasil vaccine, which has brought many improvements in its safety and effectiveness.
The new generation of Gardasil vaccine
Gardasil 9 is the new generation of Gardasil vaccine, which in addition to covering four main types of virus (HPV 6, 11, 16, and 18), also includes five additional types of virus (HPV 31, 33, 45, 52, and 58). This vaccine can provide more protection against more types of HPV.
